Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction

Recruiting N/A Interventional Study
Erectile Dysfunction Following Radical Prostatectomy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
30 – 70
Sex
Male
Study type
Interventional
Purpose
Treatment
Participants needed
20 (estimated)
Sponsor
Comphya Australia · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to assess if a new device is safe to use as a potential treatment for erectile dysfunction following radical prostatectomy. The main questions it aims to answer are: * Is the device safe? * Does the device works well? Are the participants satisfied with the device? Participants will be implanted with the device during the ongoing prostatectomy surgery and will…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Men of ages between 30-70 years; * Men with indication for nerve-sparing prostatectomy surgery; * Localised prostate cancer considered suitable for bilateral nerve sparing prostatectomy according to clinical criteria * International Index of Erectile Function (IIEF-15) erectil…
Contacts

Helen Crowe

+61 3 8373 7600

helenrcrowe@gmail.com

CONTACT